The WAP protein Trappin-2/Elafin: A handyman in the regulation of inflammatory and immune responses

International Journal of Biochemistry and Cell Biology

Volumn 44, Issue 8, 2012, Pages 1377-1380

  Verrier, Thomas ^a,b,c   Solhonne, Brigitte ^b,c   Sallenave, Jean Michel ^b,c,d   Garcia Verdugo, Ignacio ^b,c,d  

^a UNIVERSITÉ DE LYON   (France)

^b INSTITUT PASTEUR   (France)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Anti microbial; Elafin; Inflammation; Neutrophil elastase; Trappin 2; WAP

Indexed keywords

CYTOKINE; ELAFIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRAPPIN 2; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; CYTOKINE RELEASE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INFLAMMATION; MACROPHAGE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE;

FUNGI;

EID: 84861797426     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2012.05.007     Document Type: Short Survey

References (30)

1. Baranger K, Zani ML, Chandenier J, Dallet-Choisy S, Moreau T. The antibacterial and antifungal properties of Trappin-2 (pre-elafin) do not depend on its protease inhibitory function. FEBS Journal 2008;275:2008-20. (Pubitemid 351569543)
2. Butler MW, Robertson I, Greene CM, O'Neill SJ, Taggart CC, McElvaney NG. Elafin prevents lipopolysaccharide-induced AP-1 and NF-kappaB activation via an effect on the ubiquitin-proteasome pathway. Journal of Biological Chemistry 2006;281:34730-5. (Pubitemid 46036512)
3. Drannik AG, Nag K, Yao XD, Henrick BM, Jain S, Ball TB, et al. Anti-HIV-1 activity of Elafin is more potent than its precursor's, trappin-2, in genital epithelial cells. Journal of Virology 2012a;86:4599-610.
4. Drannik AG, Nag K, Yao XD, Henrick BM, Sallenave JM, Rosenthal KL. Trappin-2/Elafin modulate innate immune responses of human endometrial epithelial cells to polyI:C. PLoS One 2012b;7(4):e35866, http://dx.doi.org/10. 1371/journal.pone.0035866.
5. Duffy CL, Phillips SL, Klingelhutz AJ. Microarray analysis identifies differentiation-associated genes regulated by human papillomavirus type 16 E6. Virology 2003;314:196-205. (Pubitemid 37153310)
6. Ghosh M, Fahey JV, Shen Z, Lahey T, Cu-Uvin S, Wu Z, et al. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies. PLoS One 2010;5:e11366.
7. Guyot N, Zani ML, Berger P, Dallet-Choisy S, Moreau T. Proteolytic susceptibility of the serine protease inhibitor trappin-2 (pre-elafin): evidence for tryptase-mediated generation of elafin. Biological Chemistry 2005;386:391-9. (Pubitemid 41447602)
8. Ho SC, Lee KY, Chan YF, Kuo LW, Ito K, Adcock IM, et al. Neutrophil elastase represses IL-8/CXCL8 synthesis in human airway smooth muscle cells through induction of NF-kappa B repressing factor. Journal of Immunology 2009;183:411-20.
9. Hochstrasser K, Albrecht GJ, Schonberger OL, Rasche B, Lempart K. An elastase-specific inhibitor from human bronchial mucus. Isolation and characterization. Hoppe-Seylers Zeitschrift fur Physiologische Chemie 1981;362:1369-75. (Pubitemid 12167425)
10. Hornsby MJ, Huff JL, Kays RJ, Canfield DR, Bevins CL, Solnick JV. Helicobacter pylori induces an antimicrobial response in rhesus macaques in a cag pathogenicity island-dependent manner. Gastroenterology 2008;134:1049-57. (Pubitemid 351451972)
11. Iqbal SM, Ball TB, Levinson P, Maranan L, Jaoko W, Wachihi C, et al. Elevated Elafin/Trappin-2 in the female genital tract is associated with protection against HIV acquisition. AIDS 2009;23:1669-77.
12. Kramps JA, Klasen EC. Characterization of a low molecular weight anti-elastase isolated from human bronchial secretion. Experimental Lung Research 1985;9:151-65. (Pubitemid 16207638)
13. Kretschmar S, Yin L, Roberts F, London R, Flemmig TT, Arushanov D, et al. Protease inhibitor levels in periodontal health and disease. Journal of Periodontal Research 2012;47:228-35.
14. Marischen L, Wesch D, Schroder JM, Wiedow O, Kabelitz D. Human gammadelta T cells produce the protease inhibitor and antimicrobial peptide elafin. Scandinavian Journal of Immunology 2009;70:547-52.
15. McMichael JW, Roghanian A, Jiang L, Ramage R, Sallenave JM. The antimicrobial antiproteinase elafin binds to lipopolysaccharide and modulates macrophage responses. American Journal of Respiratory Cell and Molecular Biology 2005;32:443-52. (Pubitemid 40629330)
16. Novick D, Rubinstein M, Azam T, Rabinkov A, Dinarello CA, Kim SH. Proteinase 3 is an IL-32 binding protein. Proceedings of the National Academy of Sciences of the United States of America 2006;103:3316-21. (Pubitemid 43346467)
17. Roghanian A, Williams SE, Sheldrake TA, Brown TI, Oberheim K, Xing Z, et al. The antimicrobial/elastase inhibitor elafin regulates lung dendritic cells and adaptive immunity. American Journal of Respiratory Cell and Molecular Biology 2006;34:634-42.
18. Sallenave JM, Ryle AP. Purification and characterization of elastase-specific inhibitor. Sequence homology with mucus proteinase inhibitor. Biological Chemistry Hoppe-Seyler 1991;372:13-21.
19. Schalkwijk J, de Roo C, de Jongh GJ. Skin-derived antileukoproteinase (SKALP), an elastase inhibitor from human keratinocytes. Purification and biochemical properties. Biochimica et Biophysica Acta 1991;1096:148-54.
20. Schalkwijk J, Wiedow O, Hirose S. The trappin gene family: proteins defined by an N-terminal transglutaminase substrate domain and a C-terminal four-disulphide core. Biochemical Journal 1999;340(Pt 3):569-77. (Pubitemid 29312852)
21. Shaw L, Wiedow O. Therapeutic potential of human elafin. Biochemical Society Transactions 2011;39:1450-4.
22. Simpson AJ, Cunningham GA, Porteous DJ, Haslett C, Sallenave JM. Regulation of adenovirus-mediated elafin transgene expression by bacterial lipopolysaccharide. Human Gene Therapy 2001a;12:1395-406. (Pubitemid 32881345)
23. Simpson AJ, Wallace WA, Marsden ME, Govan JR, Porteous DJ, Haslett C, et al. Adenoviral augmentation of elafin protects the lung against acute injury mediated by activated neutrophils and bacterial infection. Journal of Immunology 2001b;167:1778-86. (Pubitemid 32703182)
24. Stock SJ, Duthie L, Tremaine T, Calder AA, Kelly RW, Riley SC. Elafin (SKALP/Trappin-2/proteinase inhibitor-3) is produced by the cervix in pregnancy and cervicovaginal levels are diminished in bacterial vaginosis. Reproductive Sciences 2009;16:1125-34.
25. Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY, et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 2011;332:478-84.
26. Vachon E, Bourbonnais Y, Bingle CD, Rowe SJ, Janelle MF, Tremblay GM. Antiinflammatory effect of pre-elafin in lipopolysaccharide-induced acute lung inflammation. Biological Chemistry 2002;383:1249-56. (Pubitemid 35221305)
27. Wiedow O, Schroder JM, Gregory H, Young JA, Christophers E. Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. Journal of Biological Chemistry 1990;265: 14791-5.
28. Wilkinson TS, Dhaliwal K, Hamilton TW, Lipka AF, Farrell L, Davidson DJ, et al. Trappin-2 promotes early clearance of Pseudomonas aeruginosa through CD14-dependent macrophage activation and neutrophil recruitment. American Journal of Pathology 2009;174:1338-46.
29. Williams SE, Brown TI, Roghanian A, Sallenave JM. SLPI and elafin: one glove, many fingers. Clinical Science (London) 2006;110:21-35. (Pubitemid 43059043)
30. Zhu J, Nathan C, Jin W, Sim D, Ashcroft GS, Wahl SM, et al. Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell 2002;111:867-78. (Pubitemid 36106407)